Home › GLP-1 Medications › Eli Lilly › Mounjaro
Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each model brings the brand up in recommendation answers.
| model | share of voice | answers |
|---|---|---|
| ChatGPT | 83% | 20 of 24 |
| Claude | 96% | 23 of 24 |
| Gemini | 58% | 14 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 79% | 57 of 72 |
Recurring descriptions in the models' own words, grouped by theme.
“Mounjaro is a first-in-class dual GIP and GLP-1 receptor agonist.”
“If you **do not** have Type 2 diabetes, insurance will almost certainly deny coverage for Mounjaro. You will have to pay the full out-of-pocket retail price (often upwards of $1,000/month).”
“If you do not have Type 2 diabetes and your goal is chronic weight management, **Zepbound** is the correct choice.”
“They are administered as a weekly injection, have the same side effects, and come in the exact same doses (ranging from 2.”
“Rybelsus is a daily oral tablet, whereas Mounjaro is a once-weekly subcutaneous injection.”
“* **Your primary goals are maximum weight loss and superior blood sugar control:** Mounjaro is a dual-action medication (targeting both GIP and GLP-1 receptors), making it highly effective.”
“If your insurance covers them, or if you qualify for the manufacturers' copay savings cards, you could pay as little as **$25 per month**.”
“If you need a GLP-1 receptor agonist to control your blood sugar but dread the idea of weekly injections (like standard Ozempic, Trulicity, or Mounjaro), Rybelsus is highly effective.”
“(Zepbound is not approved for diabetes; its sister drug, Mounjaro, is).”
“**Short answer:** for many people with **type 2 diabetes**, Mounjaro (tirzepatide) is worth considering—especially if you also want substantial weight loss and have not met your A1C goals with other treatment.”
204 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.
“In head-to-head clinical trials, Mounjaro has shown the strongest results for both blood sugar reduction and weight loss. It also has robust cardiovascular benefits.”
“If you have commercial insurance, Lilly's current Mounjaro savings program may reduce the cost to as little as **$25 for up to a 3-month fill**”
“eligible patients can lower Mounjaro or Zepbound copays to as little as $25 for up to 12 fills per year”
“Technically a dual GIP and GLP-1 receptor agonist, Mounjaro acts on two hunger-regulating and insulin-stimulating pathways instead of just one. In clinical trials, it has shown some of the most powerful A1C-lowering and weight-reduction res”
“**Mounjaro.** Here's why, based on the clinical evidence: **Efficacy is significantly higher.**”
“It contains the same active medication as Mounjaro (**tirzepatide**), but Zepbound is the version specifically FDA-approved for chronic weight management; Mounjaro is labeled primarily for type 2 diabetes glucose control.”
“Finding the best deal on a GLP-1 medication (like Wegovy, Ozempic, Zepbound, or Mounjaro)”
“**Tirzepatide** – sold as Mounjaro (diabetes) and Zepbound (weight loss); a dual GLP-1/GIP agonist”
“Mounjaro (tirzepatide) is a once-weekly GIP/GLP‑1 medicine FDA-approved for **type 2 diabetes**; it commonly also produces meaningful weight loss.”
“stopping popular weight-loss injections like Ozempic or Mounjaro might not trigger the dramatic rebound many fear”
“**Do not choose Ozempic or Mounjaro solely because they are popular.** They contain the same active ingredients as Wegovy and Zepbound, respectively, but are branded and FDA-approved primarily for type 2 diabetes”
“Buying Ozempic or Mounjaro solely [for weight loss is not recommended, implied by the warning section]”
“Brand-name weekly GLP-1s (like Ozempic, Wegovy, or Mounjaro) do not have generic options yet and routinely cost upwards of $900 to $1,000+ per month without insurance.”
“Do **not** simply substitute Ozempic/Mounjaro for Wegovy/Zepbound on your own.”
“Do not buy Ozempic or Mounjaro "for weight loss" on your own; they are branded for diabetes, while **Wegovy and Zepbound** are the FDA-approved brands specifically for chronic weight management.”
Which competitors models suggest when shoppers ask for something cheaper.
30 of 204 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| noom.com | 4 |
| goodrx.com | 4 |
| injectco.com | 3 |
| pandameds.com | 3 |
| peptidedeck.com | 2 |
| formblends.com | 2 |
| preventionclinics.com | 2 |
| doctronic.ai | 2 |
| glpchart.com | 1 |
| cochrane.org | 1 |
| everydayhealth.com | 1 |
| fda.gov | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.